Randomized, multicentre, double-blind clinical trial designed to evaluate the safety and convenience of switching from DTG/3TC to B/F/TAF in people with HIV, good virological control and neuropsychiatric comorbidity: week 24 results from the GESIDA 11920 -MIND study